Shalby Ltd
SHALBYShalby Ltd
SHALBYPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
43.85 | 2.38 | 0.54% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.27 | 6.55 | 0.51% |
Forecast & Ratings
Detailed Forecast from 1 analyst
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Shalby Limited operates a multi-specialty chain of hospitals. Its hospitals are tertiary care hospitals, which offer quaternary healthcare services
Peers
Compare with peersApollo Hospitals Enterprise Ltd
Max Healthcare Institute Ltd
Fortis Healthcare Ltd
Global Health Ltd
Narayana Hrudayalaya Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ cr.
All values in ₹ cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 292.56 | 330.52 | 388.00 | 471.52 | 504.22 | 439.96 | 711.37 | 827.44 | 953.18 | 1,033.08 | ||||||||||
Raw Materials | 4.40 | 36.70 | 39.68 | 39.85 | 52.80 | 34.30 | 153.38 | 104.63 | 108.21 | 847.66 | ||||||||||
Power & Fuel Cost | 6.79 | 7.59 | 9.43 | 12.66 | 12.98 | 12.31 | 14.49 | 16.25 | 19.70 | |||||||||||
Employee Cost | 28.92 | 38.90 | 45.08 | 64.60 | 65.50 | 56.96 | 114.74 | 143.64 | 155.44 | |||||||||||
Selling & Administrative Expenses | 14.81 | 17.58 | 20.56 | 19.59 | 21.04 | 13.61 | 36.89 | 61.30 | 66.75 | |||||||||||
Operating & Other expenses | 179.93 | 151.51 | 184.31 | 242.07 | 251.75 | 226.39 | 262.32 | 340.92 | 405.03 | |||||||||||
EBITDA | 57.71 | 78.24 | 88.94 | 92.75 | 100.15 | 96.39 | 129.55 | 160.70 | 198.05 | 185.42 | ||||||||||
Depreciation/Amortization | 11.33 | 16.70 | 22.86 | 33.17 | 36.02 | 36.80 | 42.87 | 48.09 | 52.24 | 61.21 | ||||||||||
PBIT | 46.38 | 61.54 | 66.08 | 59.58 | 64.13 | 59.59 | 86.68 | 112.61 | 145.81 | 124.21 | ||||||||||
Interest & Other Items | 10.45 | 11.04 | 12.37 | 9.18 | 7.41 | 4.54 | 7.53 | 10.56 | 17.62 | 27.48 | ||||||||||
PBT | 35.93 | 50.50 | 53.71 | 50.40 | 56.72 | 55.05 | 79.15 | 102.05 | 128.19 | 96.73 | ||||||||||
Taxes & Other Items | -1.66 | 20.80 | 14.35 | 18.73 | 29.14 | 12.66 | 25.02 | 34.35 | 44.12 | 41.99 | ||||||||||
Net Income | 37.59 | 29.70 | 39.36 | 31.67 | 27.58 | 42.39 | 54.13 | 67.70 | 84.07 | 54.74 | ||||||||||
EPS | 4.30 | 3.40 | 4.03 | 2.93 | 2.55 | 3.92 | 5.01 | 6.29 | 7.83 | 5.10 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.50 | 0.50 | 1.00 | 1.00 | 1.20 | 1.20 | 1.20 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.17 | 0.20 | 0.25 | 0.20 | 0.19 | 0.15 | 0.24 |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Shalby Ltd | 28.55 | 2.38 | 0.54% |
Apollo Hospitals Enterprise Ltd | 118.75 | 14.58 | 0.22% |
Max Healthcare Institute Ltd | 99.20 | 12.48 | 0.14% |
Fortis Healthcare Ltd | 78.25 | 5.48 | 0.16% |
Price Comparison
Compare SHALBY with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding Shalby Ltd
Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Bandhan BSE Healthcare Index Fund Direct Plan-Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.06% | Change in the portfolio weight of the stock over the last 3 months 0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 91/102 (-5) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
SHALBY has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.51%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹5.10 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 19, 2024
Dividend/Share
₹1.20
Ex DateEx Date
Sep 19, 2024
Cash Dividend
Ex DateEx DateAug 8, 2023
Dividend/Share
₹1.20
Ex DateEx Date
Aug 8, 2023
Cash Dividend
Ex DateEx DateSep 19, 2022
Dividend/Share
₹1.00
Ex DateEx Date
Sep 19, 2022
Cash Dividend
Ex DateEx DateSep 17, 2021
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2021
Cash Dividend
Ex DateEx DateSep 4, 2020
Dividend/Share
₹0.50
Ex DateEx Date
Sep 4, 2020
Net profit of Shalby declined 87.71% to Rs 3.39 crore in the quarter ended September 2024 as against Rs 27.58 crore during the previous quarter ended September 2023. Sales rose 12.42% to Rs 267.54 crore in the quarter ended September 2024 as against Rs 237.98 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales267.54237.98 12 OPM %12.2022.15 - PBDT30.5554.93 -44 PBT13.7042.63 -68 NP3.3927.58 -88 Powered by Capital Market - Live
Shalby announced that the 20th Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live
Shalby jumps on bagging 30-year lease for Asha Parekh Hospital
Shalby consolidated net profit declines 29.24% in the June 2024 quarter
Shalby drops after PAT slides 20% YoY to Rs 16 cr in Q1 FY25
Shalby Ltd’s net profit falls 20% in June quarter of FY25; stock slips 7%
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 15.12%, vs industry avg of 10.02%
Increasing Market Share
Over the last 5 years, market share increased from 1.29% to 1.54%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 21.56%, vs industry avg of 42.9%